FBT
BMY icon

First Bank & Trust’s Bristol-Myers Squibb BMY Stock Holding History

First Bank & Trust’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$308K Sell
5,353
-37
-0.7% -$2.13K 0.05% 214
2026
Q1 		$327K Sell
5,390
-658
-11% -$38.4K 0.05% 191
2025
Q4 		$326K Sell
6,048
-671
-10% -$32.3K 0.05% 198
2025
Q3 		$303K Sell
6,719
-21,612
-76% -$1.01M 0.05% 200
2025
Q2 		$1.31M Sell
28,331
-36,386
-56% -$1.79M 0.23% 85
2025
Q1 		$3.95M Buy
64,717
+4,449
+7% +$259K 0.76% 30
2024
Q4 		$3.41M Buy
60,268
+19,878
+49% +$1.11M 0.65% 35
2024
Q3 		$2.09M Buy
40,390
+11,233
+39% +$527K 0.4% 60
2024
Q2 		$1.21M Buy
29,157
+8,950
+44% +$400K 0.25% 83
2024
Q1 		$1.1M Buy
+20,207
New +$1.03M 0.23% 89
2023
Q2 		– Sell
-2,952
Closed -$205K – 199
2023
Q1 		$205K Sell
2,952
-16,339
-85% -$1.15M 0.05% 185
2022
Q4 		$1.39M Sell
19,291
-5,090
-21% -$384K 0.39% 64
2022
Q3 		$1.73M Sell
24,381
-1,937
-7% -$141K 0.64% 42
2022
Q2 		$2.03M Sell
26,318
-6,817
-21% -$519K 0.66% 36
2022
Q1 		$2.42M Buy
33,135
+15,488
+88% +$1.04M 0.75% 29
2021
Q4 		$1.1M Buy
17,647
+14,372
+439% +$843K 0.46% 64
2021
Q3 		$194K Sell
3,275
-212
-6% -$14K 0.09% 166
2021
Q2 		$232K Sell
3,487
-310
-8% -$20.2K 0.11% 153
2021
Q1 		$239K Sell
3,797
-12,917
-77% -$804K 0.12% 145
2020
Q4 		$1.04M Buy
16,714
+4,984
+42% +$306K 0.66% 46
2020
Q3 		$708K Buy
11,730
+8,751
+294% +$527K 0.47% 66
2020
Q2 		$175K Buy
2,979
+23
+0.8% +$1.38K 0.13% 134
2020
Q1 		$165K Buy
2,956
+3
+0.1% +$183 0.15% 121
2019
Q4 		$190K Buy
+2,953
New +$169K 0.14% 142
2019
Q3 		– Sell
-19
Closed -$1K – 405
2019
Q2 		$1K Buy
+19
New +$885 ﹤0.01% 434
2017
Q1 		– Sell
-186
Closed -$11K – 249
2016
Q4 		$11K Buy
+186
New +$10.2K 0.01% 219

Other funds holding BMY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
FWIA
Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return

First Bank & Trust's BMY Position: Q2 2026 in Review

First Bank & Trust reduced its Bristol-Myers Squibb (BMY) stake by 0.69% in Q2 2026, selling an estimated $2.13K and leaving 5,353 shares worth $308K. The position accounts for 0.05% of the portfolio, ranked #214.

First Bank & Trust first reported a position in BMY in Q4 2016 and has held it in 26 quarters since. The position peaked at $3.95M in Q1 2025. 878 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • First Bank & Trust held 5,353 shares of Bristol-Myers Squibb worth $308K as of Q2 2026.
  • First Bank & Trust sold 37 Bristol-Myers Squibb shares in Q2 2026, an estimated $2.13K.
  • Bristol-Myers Squibb made up 0.05% of First Bank & Trust's portfolio in Q2 2026, its #214 holding.
  • First Bank & Trust first reported a position in Bristol-Myers Squibb in Q4 2016 and has held it in 26 quarters since.
  • First Bank & Trust's Bristol-Myers Squibb position peaked at $3.95M in Q1 2025.
  • 878 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on First Bank & Trust's 13F filing for Q2 2026, filed 9 Jul 2026.